By Mary Gabb (mary.gabb@rxcomms.com) Nowadays, healthcare is hotly debated, and not just for US presidential candidates. Virtually every western country is now grappling with the challenge of how to pay…
Details
By Heather Haley (heather.haley@rxcomms.com) Ever asked yourself: “Is there a better way to do this?” while sifting through 300 plus potential articles. PubMed offers several features that can dramatically improve…
Details
By Ruth Whittington (ruth.whittington@rxcomms.com) The World Healthcare Congress, held March 10 – 13 in Berlin, always provides interesting insights on the ways governments, clinicians, and healthcare providers perceive healthcare delivery.…
Details
By David Woods (david.woods@rxcomms.com) The pharmaceutical industry is too often blamed for the stratospheric costs of healthcare — particularly in the United States. Yet, according to a series of surveys…
Details
By Mary Gabb (mary.gabb@rxcomms.com) With all of the recent news about job cuts or outsourcing in the pharmaceutical industry, health economists maybe worried about their own employment, as the downturn…
Details
By David Woods (david.woods@rxcomms.com) With this the 26th issue of HOC, we are well overdue in featuring our energetic, globetrotting CEO of Rx Communications, Ruth Whittington. I can say this…
Details
By Julie Stauffer (julie.stauffer.rxcomms.com) Sustaining staff morale is about much more than delivering a wage slip at the end of the month. If the past few years of restructurings, closures,…
Details
By Mary Gabb (mary.gabb@rxcomms.com) Obnoxious, annoying, Big Pharma strikes again – these are just some of the sentiments heard when encountering a direct-to-consumer (DTC) advertisement, the myriad commercials on radio…
Details
By David Woods (david.woods@rxcomms.com) There has been much written lately about the perceived failings of the FDA. The Wall Street Journal claims that “the place is a mess,” and a…
Details
By Mary Gabb (mary.gabb@rxcomms.com) As health economics plays a more prominent role in medical research and public policy, participation in panel discussions – either in front of a live audience…
Details
